Remus Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | ||
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 45.03 | 24.72 | 18.42 | 11.92 | |
| Expenses | |||||
| Material consumed | 21.44 | 12.27 | 11.49 | 7.04 | |
| Manufacturing expenses | - | - | - | - | |
| Personnel expenses | 5.47 | 3.49 | 3.00 | 2.86 | |
| Selling expenses | - | - | - | - | |
| Adminstrative expenses | 7.57 | 4.89 | 3.17 | 1.63 | |
| Expenses capitalised | - | - | - | - | |
| Cost of sales | 34.48 | 20.65 | 17.66 | 11.53 | |
| Operating profit | 10.55 | 4.07 | 0.76 | 0.39 | |
| Other recurring income | 1.58 | 0.72 | 0.81 | 0.85 | |
| Adjusted PBDIT | 12.12 | 4.79 | 1.57 | 1.24 | |
| Financial expenses | 0.23 | 0.09 | 0.04 | 0.04 | |
| Depreciation | 0.48 | 0.15 | 0.18 | 0.11 | |
| Other write offs | - | - | - | - | |
| Adjusted PBT | 11.41 | 4.55 | 1.36 | 1.09 | |
| Tax charges | 2.91 | 1.16 | 0.33 | 0.28 | |
| Adjusted PAT | 8.50 | 3.39 | 1.03 | 0.81 | |
| Non recurring items | - | - | - | - | |
| Other non cash adjustments | - | - | - | - | |
| Reported net profit | 8.50 | 3.39 | 1.03 | 0.81 | |
| Earnigs before appropriation | 14.08 | 6.42 | 3.04 | 2.01 | |
| Equity dividend | - | - | - | - | |
| Preference dividend | - | - | - | - | |
| Dividend tax | - | - | - | - | |
| Retained earnings | 14.08 | 6.42 | 3.04 | 2.01 | |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis